Josamycin

交沙霉素

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameJosamycin
Drug Alias Name交沙酶素josamicina茭杀霉素Leucomycin A3罗红霉素 +[12] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibiotics
Mechanisms of Action50S ribosomal subunit inhibitors
Targets50S ribosomal subunit
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryJapan
Original Approved Date1970/06/01
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesLtl Pharma Co LtdGuangzhou Baiyunshan Guanghua Pharmacy Co Ltd
Inactive CompaniesN/A
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ01FA07
Related LinksWikipediaDrugBankKEGG